Viropro, Inc. (VPRO)

[Alphavol]

With a better business model, an attractiver pipeline than similar company Juno Therapeutics. A few months ago Juno was even worth $6bn mcap. We do have enough information Axxiom has the potential to get there, upon confirmation (Merger, other LOIs, Nasdaq, etc.) your stake will be worth $3+. Other elements such as short covering, tight free float will help. Go VPRO/Axxiom